Shree Hari Chemicals FY26 Revenue Rises, Net Profit Declines
Shree Hari Chemicals Export Limited reported its audited financial results for FY26, showing a rise in standalone revenue to Rs. 18,450.48 lakhs from Rs. 14,119.58 lakhs in the previous year. However, standalone net profit declined to Rs. 422.22 lakhs from Rs. 512.40 lakhs. On a consolidated basis, total income reached Rs. 18,763.84 lakhs with a net profit of Rs. 411.81 lakhs. The company confirmed no deviations in preferential issue utilization and reported outstanding qualified borrowings of Rs. 28.38 crores.

*this image is generated using AI for illustrative purposes only.
Shree Hari Chemicals Export Limited's Board of Directors approved the audited standalone and consolidated financial statements for the year ended March 31, 2026. The results were reviewed by the Audit Committee and received an unmodified opinion from auditors Kailash Chand Jain & Co.
Standalone Financial Performance
On a standalone basis, the company recorded revenue from operations of Rs. 18,450.48 lakhs for FY26, compared to Rs. 14,119.58 lakhs in FY25. Total income stood at Rs. 18,756.27 lakhs. Net profit for the year declined to Rs. 422.22 lakhs from Rs. 512.40 lakhs in the previous year. Total comprehensive income for FY26 was Rs. 421.01 lakhs.
| Particulars | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Revenue from Operations | 18,450.48 | 14,119.58 |
| Total Income | 18,756.27 | 14,206.70 |
| Total Expenses | 18,226.69 | 13,511.20 |
| Net Profit | 422.22 | 512.40 |
| Basic EPS (Rs.) | 8.23 | 11.47 |
Consolidated Financial Performance
On a consolidated basis, total income for FY26 was Rs. 18,763.84 lakhs (FY25: Rs. 14,206.70 lakhs). Consolidated net profit was Rs. 411.81 lakhs versus Rs. 509.75 lakhs in FY25. Total comprehensive income attributable to owners was Rs. 410.61 lakhs.
| Particulars | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Revenue from Operations | 18,450.48 | 14,119.58 |
| Total Income | 18,763.84 | 14,206.70 |
| Net Profit | 411.81 | 509.75 |
| Basic EPS (Rs.) | 8.03 | 11.41 |
Balance Sheet and Cash Flow
The standalone balance sheet as of March 31, 2026, reflects total assets of Rs. 10,242.83 lakhs, up from Rs. 8,662.52 lakhs. Equity share capital stood at Rs. 553.79 lakhs. The standalone cash flow statement shows cash generated from operating activities of Rs. 1,105.64 lakhs, compared to an outflow of Rs. (147.26) lakhs in the prior year. The closing cash balance was Rs. 55.37 lakhs.
Regulatory Disclosures
Pursuant to Regulation 32(1), the company confirmed no deviations in the utilization of proceeds from its Preferential Issue, which raised Rs. 14,74,59,820. Regarding the SEBI Circular on Large Corporates, outstanding qualified borrowings at the end of FY26 were Rs. 28.38 crores, with no incremental borrowing or debt securities issued during the year.
Historical Stock Returns for Shree Hari Chemicals Export
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.22% | -6.95% | +15.10% | -18.74% | -25.57% | +79.98% |
Given the significant increase in revenue but declining net profit margins in FY26, what cost optimization strategies is Shree Hari Chemicals Export likely to implement to restore profitability in FY27?
With capital work-in-progress nearly doubling to Rs. 764.88 lakhs and investments surging from Rs. 104.66 to Rs. 1,221.99 lakhs, what capacity expansion or diversification projects are underway and how might they impact future revenue growth?
How could rising current borrowings (up to Rs. 2,563.39 lakhs) combined with minimal cash reserves of Rs. 55.37 lakhs affect the company's ability to service debt and fund working capital requirements in FY27?


































